A5033387038- Esophageal Cancer Research and Treatment
- Tuberculosis Research and Epidemiology
- scientometrics and bibliometrics research
- Public health and occupational medicine
- Nutrition and Health Studies
- Esophageal and GI Pathology
- Advanced Breast Cancer Therapies
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
- demographic modeling and climate adaptation
- Healthcare Policy and Management
- Polish Historical and Cultural Studies
- Economic and Financial Impacts of Cancer
- Pharmaceutical studies and practices
- Pharmacology and Obesity Treatment
- Diverse Academic Research Studies
- Eosinophilic Esophagitis
- Neuroendocrine Tumor Research Advances
- Cancer survivorship and care
- Patient-Provider Communication in Healthcare
- Health Systems, Economic Evaluations, Quality of Life
- Medication Adherence and Compliance
- Diagnosis and treatment of tuberculosis
- Food Security and Health in Diverse Populations
- Smoking Behavior and Cessation
Novartis (United States)
2017
Dana-Farber Cancer Institute
2015-2016
Massachusetts General Hospital
2012-2015
Harvard University
2014-2015
University of California, Los Angeles
2015
University of Washington
2014
Fred Hutch Cancer Center
2014
University of Michigan–Ann Arbor
2014
Erasmus MC
2014
Erasmus University Rotterdam
2014
Over the past several decades, incidence of esophageal adenocarcinoma (EAC) has rapidly increased. The purpose this analysis was to examine temporal trends in EAC and mortality within US population and, addition, explore these subgroups population.The National Cancer Institute (NCI) Surveillance, Epidemiology End Results (SEER 9) data were used incidence-based (IB) from 1975 2009. Secular IB by cancer stage, sex, race further characterized using NCI's Joinpoint Regression program.Based on...
The incidence of esophageal adenocarcinoma (EAC) has increased five-fold in the United States since 1975. aim our study was to estimate future U.S. EAC and mortality shed light on potential drivers disease process that are conduits for dramatic increase incidence.
Background. The EQ-5D and SF-6D are 2 health-related quality-of-life indexes that provide preference-weighted measures for use in cost-effectiveness analyses. Methods. National Cancer Institute’s Care Outcomes Research Surveillance (CanCORS) Consortium included the SF-12v2 their survey of newly diagnosed lung cancer patients. Utilities were calculated from patient-provided scores each domain or SF-6D. categories type, stage, treatment. Results. There 5015 enrolled patients with a baseline...
Population-level research on the implications of retail pharmacy policies to end sale tobacco products is scant, and impact such racial/ethnic socioeconomic disparities across neighborhoods in access remains unexplored.
<p>PDF - 1235K, Referred to as "Appendix". Supplementary Materials and Methods. Figure A1. Schematic diagram of MSEAC Model. A2. Cell Proliferation Rates by Birth Cohort, Males. A3. Females. A4. Period Cohort Effects Applied Conceptual Model Transitions. A5. Effect Coefficient Values a Function Calendar Year for A6. A7. Structure UW-MISCAN Esophageal Adenocarcinoma A8. Increasing or Plateauing the EAC Incidence Trend Age Group. A9. The incidence rates stratified birth cohorts are shown...
<div>Abstract<p><b>Background:</b> The incidence of esophageal adenocarcinoma (EAC) has increased five-fold in the United States since 1975. aim our study was to estimate future U.S. EAC and mortality shed light on potential drivers disease process that are conduits for dramatic increase incidence.</p><p><b>Methods:</b> A consortium three research groups calibrated independent mathematical models clinical epidemiologic data including from...
<div>Abstract<p><b>Background:</b> The incidence of esophageal adenocarcinoma (EAC) has increased five-fold in the United States since 1975. aim our study was to estimate future U.S. EAC and mortality shed light on potential drivers disease process that are conduits for dramatic increase incidence.</p><p><b>Methods:</b> A consortium three research groups calibrated independent mathematical models clinical epidemiologic data including from...
<p>PDF - 1235K, Referred to as "Appendix". Supplementary Materials and Methods. Figure A1. Schematic diagram of MSEAC Model. A2. Cell Proliferation Rates by Birth Cohort, Males. A3. Females. A4. Period Cohort Effects Applied Conceptual Model Transitions. A5. Effect Coefficient Values a Function Calendar Year for A6. A7. Structure UW-MISCAN Esophageal Adenocarcinoma A8. Increasing or Plateauing the EAC Incidence Trend Age Group. A9. The incidence rates stratified birth cohorts are shown...